# Dvant Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dvant-pharma

- Industry: Pharmaceuticals
- Headquarters: US
- Total disclosed funding: $1.2M
- Latest round: Seed (Apr 12, 2021)
- Investors on record: 2

## About

Based in Delaware, US, Dvant Pharma Inc. provides drugs that are used in the treatment of cancer. In April 2021, the firm raised USD 1.23 million in Seed funding from investors Venture Investors and Transhuman Capital, with participation from an individual investor.

The company manufactures pharmaceutical products for the treatment of cancer and tumor.

## Funding rounds

- Seed, Apr 12, 2021, $1.2M — Venture Investors, Transhuman Capital

## Investors

- Venture Investors — Seed
- Transhuman Capital (https://capitalatlas.ai/funds/transhuman-capital) — Seed
